This page includes the latest FDA filings for Alimera Sciences Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | ALIM | DUNS 135745292 |
Device Company | Device | Date |
|---|---|---|
| Alimera Sciences, Inc. | Prescription Medication | 2025-03-26 |
| Alimera Sciences, Inc. | Prescription Medication | 2024-12-05 |
| Alimera Sciences, Inc. | Prescription Medication | 2023-11-08 |
| Alimera Sciences, Inc. | Prescription Medication | 2023-10-17 |
| Alimera Sciences, Inc. | Prescription Medication | 2023-09-16 |
| Alimera Sciences, Inc. | Prescription Medication | 2022-11-18 |
| Alimera Sciences, Inc. | Prescription Medication | 2022-01-18 |
| Alimera Sciences, Inc. | Prescription Medication | 2019-12-05 |
| Alimera Sciences, Inc. | Prescription Medication | 2019-09-11 |
| Alimera Sciences, Inc. | Iluvien | 2014-10-15 |
ALIMERA SCIENCES INC | 0000-00-00 00:00:00 |
| NCAGE Code | 7AF65 | ALIMERA SCIENCES, INC. |
| CAGE Code | 7AF65 | ALIMERA SCIENCES, INC. |
| S.A.M. Registration | 7AF65 [135745292] | ALIMERA SCIENCES, INC. |
| SEC | 0001267602 | ALIMERA SCIENCES INC |